SWM
BNTX icon

Spire Wealth Management’s BioNTech BNTX Stock Holding History

Spire Wealth Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-38
Closed -$4.51K – 2448
2024
Q3 		$4.51K Hold
38
– – ﹤0.01% 1842
2024
Q2 		$3.05K Hold
38
– – ﹤0.01% 1928
2024
Q1 		$3.51K Sell
38
-11
-22% -$1.05K ﹤0.01% 1999
2023
Q4 		$4.81K Buy
49
+1
+2% +$101 ﹤0.01% 1965
2023
Q3 		$5.25K Hold
48
– – ﹤0.01% 1931
2023
Q2 		$5.18K Hold
48
– – ﹤0.01% 1992
2023
Q1 		$5.98K Sell
48
-37
-44% -$5.08K ﹤0.01% 1992
2022
Q4 		$13K Hold
85
– – ﹤0.01% 1513
2022
Q3 		$11K Sell
85
-55
-39% -$8.41K ﹤0.01% 1529
2022
Q2 		$21K Sell
140
-10
-7% -$1.53K ﹤0.01% 1644
2022
Q1 		$26K Sell
150
-755
-83% -$127K ﹤0.01% 1695
2021
Q4 		$233K Sell
905
-88
-9% -$24.1K 0.01% 1028
2021
Q3 		$271K Buy
993
+953
+2,383% +$303K 0.01% 791
2021
Q2 		$9K Sell
40
-285
-88% -$53.7K ﹤0.01% 2146
2021
Q1 		$31K Buy
+325
New +$34.5K ﹤0.01% 1956

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Spire Wealth Management's BNTX Position: Q4 2024 in Review

Spire Wealth Management sold out of BioNTech (BNTX) in Q4 2024, closing a stake of 38 shares — an estimated $4.51K sold.

Spire Wealth Management first reported a position in BNTX in Q1 2021 and held it in 15 quarters. The position peaked at $271K in Q3 2021. 303 funds tracked by Wall St. Rank hold BNTX as of Q4 2024.

  • Spire Wealth Management reported no remaining BioNTech position as of Q4 2024 after selling out during the quarter.
  • Spire Wealth Management sold 38 BioNTech shares in Q4 2024, an estimated $4.51K.
  • Spire Wealth Management first reported a position in BioNTech in Q1 2021 and held it in 15 quarters.
  • Spire Wealth Management's BioNTech position peaked at $271K in Q3 2021.
  • 303 funds tracked by Wall St. Rank held BioNTech as of Q4 2024.

Based on Spire Wealth Management's 13F filing for Q4 2024, filed 24 Jan 2025.